Hepatic Superscan on 18 F-FDG PET/CT in a Patient With Secondary Leukemia.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 40611464.
- Also identified by DOI 10.1097/RLU.0000000000005934.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Secondary leukemia can develop as a recognized side effect of chemotherapy and radiotherapy. In our case, an asymptomatic 61-year-old man was diagnosed with mixed-type Hodgkin lymphoma and underwent treatment with brentixumab-vedotin in 2021. Lately, the 18 F-FDG PET/CT scan we performed due to symptoms, revealed hepatomegaly and a diffusely increased FDG uptake in the liver. Following bone marrow biopsy revealed AML and the scan was consistent with hepatic superscan.
Medical subject headings
- Positron Emission Tomography Computed Tomography
- Fluorodeoxyglucose F18
- Liver
- Neoplasms, Second Primary